Page 281 - Read Online
P. 281

Magee et al.                                                                                                                                                                           Egr1 in liver metabolism and cancer


                                                   Growth factors, stress, insulin
                           Adipose tissue
                                Insulin resistance                  Promote or inhibit?
                                   PTEN/PI3K-AKT             EGR1            HCC
                                   GGPPS/MAPK                            Tumor suppressor
                                       Obesity                               Downregulation in HCC
                                                                             Inhibit tumor growth
                           Decrease energy expenditure                       Induce apoptosis
                           Promote inflammation                          Tumor promoter
                                                                             promote drug resistance
                                              Liver steatosis
                                            Promote or inhibit?            Liver regeneration
                                   APAP-induced liver injury and fibrosis  Promote cell-cycle
                                                                           Induce cytokines
                                                Promote acute injury
                                                Inhibit chronic injury
           Figure 2: Model of EGR1 function in metabolic diseases and liver diseases. EGR1 is induced in response to various stimuli such as
           growth factors, stress, and insulin signal. EGR1 regulates a wide array of transcriptional targets involved in multiple biological functions
           related to lipid and glucose metabolism. In particular, increase of EGR1 in adipose tissue is associated with insulin resistance and
           obesity. In the liver, dysregulation of EGR1 is associated with liver steatosis. EGR1 promotes acute acetaminophen (APAP)-induced liver
           injury while attenuates chronic APAP-induced liver fibrosis. EGR1 is important for liver regeneration as it promotes cell-cycle entry and
           progression, as well as stimulates production of cytokines required for tissue repair. Finally, dysregulation of EGR1 associates with HCC
           development. EGR1 regulates HCC tumor growth and apoptosis, and is involved in hypoxia-induced drug resistance. EGR1: early growth
           response 1; HCC: hepatocellular carcinoma

           derivative, HS-1200 [89] . Collectively, these studies   upregulation of vascular endothelial growth factor and
           have demonstrated that Egr1 functions as a tumor   IL-8 [93] . In an attempt to identify early biomarkers of
           suppressor in HCC via inhibiting tumor proliferation   HCC, Archer et al. [94]  has performed gene expression
           and promoting apoptosis.                           microarray analyses in HCC tissues and revealed
                                                              that Egr1 and vesicle associated membrane protein-2
           In addition, Egr1 regulates the expression of a large   are positively correlated to hepatitis virus-induced
           number of genes required for suppressing HCC growth,   HCC. Additionally, G protein-coupled receptor kinase2
           including PTEN [38] , a very well known tumor suppressor   overexpression reduces insulin-like growth factor
           that inhibits PI3K signaling pathway in HCC. EGR1   1-induced HCC cell proliferation and migration that
           protein sumoylation is required for activation of   is mediated by decreasing Egr1 [95] . All these studies
           PTEN transcription, in which the phosphorylation   suggest that activation of Egr1 might promote HCC
           of EGR1 by AKT at S350 and T309 allows EGR1        development.
           protein sumoylation [90] . In addition, Egr1/PTEN axis
           is essential for ribonucleotide reductase regulatory   Additionally, Egr1 is described to contribute to hypoxia-
           TP53 inducible subunit M2B (RRM2B) inhibition on   induced HCC cells’ resistance against anticancer
           HCC cell migration [91] . Recently, Wang et al. [92]  has   drugs [74,96] . One of the proposed mechanisms behind
           described a cascade, involving Egr1, microRNA-203a   such  phenomenon connects Egr1, hypoxia, and
           (miR-203a), and homeobox D3 (HOXD3), inhibits      microtubules. Egr1 is co-localized with microtubules
           HCC tumorigenesis. Through both in vitro and in vivo   and mediates hypoxia-induced stabilization of
                                                                                        [96]
           studies, the authors have demonstrated that Egr1   microtubules from disassembly . Expected, knockdown
           directly activates miR-203a expression by binding to   of Egr1 improves drug effectiveness under hypoxic
           the miR-203a promoter that results in suppression on   conditions [96] . Another mechanism connects Egr1,
           HOXD3  [92] . Taken together, these studies support an   hypoxia, and autophagy to HCC drug resistance.
           anti-tumor role of Egr1 in HCC.                    Autophagy contributes to the HCC cells resistance
                                                              against chemotherapeutic agents under hypoxic
           Contrasting the anti-tumorigenic role of Egr1 is   conditions [97-99] . Egr1  transcriptionally  regulates
           study indicating that Egr1 is associated with HCC   hypoxia-induced autophagy by binding to the promoter
           tumorigenesis. In a study using cDNA microarray and   of microtubule-associated protein 1 light chain 3 and
           chromatin immunoprecipitation (ChIP) assay to assess   promotes autophagosomes formation in HCC cells [74] .
           the genes associated with tumor angiogenesis, Egr1   Collectively, these studies suggest that inhibiting
           is identified as a key player to mediate HGF-induced   Egr1 expression or function to increase tumor cells’

                           Hepatoma Research ¦ Volume 3 ¦ November 20, 2017                               273
   276   277   278   279   280   281   282   283   284   285   286